Patents by Inventor Sabine Reyda

Sabine Reyda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9486517
    Abstract: The present invention is related to a viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV), wherein a) the particle is surrounded by a lipid membrane in which viral glycoproteins are embedded, b) the particle contains neither viral DNA nor capsids; and c) the particle contains a fusion protein comprising one or more parts of the T-cell antigen pp65 and at least one heterologous peptide, and wherein the at least one heterologous peptide is inserted at amino acid position W175 or A534 of the amino acid sequence of the T-cell antigen pp65.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: November 8, 2016
    Assignee: Vakzine Projekt Management GmbH
    Inventors: Sabine Becke, Sabine Reyda, Bodo Plachter
  • Publication number: 20130202708
    Abstract: The present invention is related to a viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV), wherein a) the particle is surrounded by a lipid membrane in which viral glycoproteins are embedded, b) the particle contains neither viral DNA nor capsids; and c) the particle contains a fusion protein comprising one or more parts of the T-cell antigen pp65 and at least one heterologous peptide, and wherein the at least one heterologous peptide is inserted at amino acid position W175 or A534 of the amino acid sequence of the T-cell antigen pp65.
    Type: Application
    Filed: April 6, 2011
    Publication date: August 8, 2013
    Applicant: Valzine Projekt Management GmbH
    Inventors: Sabine Becke, Sabine Reyda, Bodo Plachter